NIH-funded research R01 grant

Effects of a common disinfectant on gut health and liver function

Official title: Impact of benzalkonium chloride on gut microbiome and gut-liver interactions

Funded at University of Washington · NIH-10799427 · Data updated 2026-11-12

This study is looking at how a common disinfectant ingredient called benzalkonium chloride might change the bacteria in your gut and affect your liver, especially since we've been using more disinfectants during the pandemic, and it aims to help us understand any health effects from long-term exposure.

More Gut Microbiome research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 20, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$648,691
NIH project number1R01ES035021-01A1
Project IDNIH-10799427 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have been exposed to high levels of disinfectants, particularly during the COVID-19 pandemic.

Less likely to help

Patients who have not been exposed to benzalkonium chloride or similar disinfectants may not benefit from this research.

What this research studies

This research investigates how exposure to benzalkonium chloride (BAC), a widely used antimicrobial found in disinfectants, affects the gut microbiome and liver interactions. Given the increased use of disinfectants during the COVID-19 pandemic, the study aims to analyze changes in gut bacteria and their metabolism, as well as how these changes might influence liver function. By examining human fecal samples and blood levels of BAC, the research seeks to understand the potential health implications of chronic exposure to this chemical. The findings could provide insights into how BAC impacts gut health and overall metabolism.

Why it matters

Potential benefit: If successful, this research could lead to a better understanding of how disinfectant exposure affects gut health, potentially informing safer use practices.

How similar studies have gone: While the effects of BACs on gut microbiome have not been extensively studied, related research on antimicrobial exposure and gut health has shown significant impacts, suggesting potential for meaningful findings in this area.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Xu, Libin — University of Washington
  • Study coordinator: Xu, Libin

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.